MedTrace Logo

Human Papillomatosis Genotyping of Children in Thailand

NCT01304966 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 15

Last updated 2014-02-17

Study results available
· View outcomes & findings →

Summary

The purpose of the present study was to identify risk factors for more severe juvenile Recurrent Respiratory Papillomatosis (RRP) through prospective evaluation of a pediatric population in Thailand by the employing a protocol that includes staging of disease severity using above mentioned staging system at the time of each endoscopic debridement, as well as human papilloma virus (HPV) genotyping.

Conditions

Interventions

PROCEDURE

biopsy

excisional biopsy

Sponsors & Collaborators

Principal Investigators

  • Pavinee Intakorn, MD · Queen Sirikit National Institute of Child Health

  • Pavinee Intakorn, MD · Queen Sirikit National of Child Health

Eligibility

Max Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2011-03-31
Primary Completion
2012-09-30
Completion
2012-12-31

Countries

  • Thailand

Study Locations

More Related Trials

Entities

Diseases
Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01304966 on ClinicalTrials.gov